Search results
Results From The WOW.Com Content Network
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
In 1993, the FDA approved gabapentin, marketed by Pfizer under the name "Neurontin", only for treatment of seizures.Pfizer subsidiary Warner-Lambert illegally used scientific activities, including continuing medical education and research, to commercially promote gabapentin, so that within five years the drug was being widely used for the off-label treatment of pain and psychiatric conditions ...
Up to one-fifth of all drugs are prescribed off-label and amongst psychiatric drugs, off-label use rises to 31%. [3] Among use of antipsychotic medications in the United States, a shift occurred from typical agents in 1995 (84% of all antipsychotic visits) to atypical agents by 2008 (93%). Atypical use has grown far beyond substitution for the ...
Other off-label uses include cancer pain, hot sweats, certain psychiatric disorders, nicotine dependence, opioid withdrawal, migraine headaches, and restless leg syndrome. Colchicine (Colcrys) for pericarditis: colchicine is indicated for the treatment and prevention of gout, though it is also generally considered first-line treatment for acute ...
In all, drugstores, drug distributors, and health insurers lost $22 billion in market value on the day of Amazon Pharmacy's launch. [ 7 ] An analysis from Citi Research called the announcement "a disruption to the system and competitive threat that will likely shift scripts away from the retail channel."
Some antidepressants, including sertraline (Zoloft) and paroxetine (Paxil) are used off-label to treat PE. Research shows that these medications help slow down climax and improve stamina for men ...
FcεRI is a tetrameric receptor complex that binds Fc portion of the ε heavy chain of IgE. [1] It consists of one alpha ( FcεRIα – antibody binding site), one beta ( FcεRIβ – which amplifies the downstream signal), and two gamma chains ( FcεRIγ – the site where the downstream signal initiates) connected by two disulfide bridges on ...
Now, approved for weight loss under the name Zepbound, the drug is available in six doses—2.5, 5, 7.5, 10, 12.5, and 15 milligrams, according to Eli Lilly, which makes the injectable medication ...